Evidence map›Paper›PMID 38067374›Full record

ArticleCancers2023

Magnetic Resonance Imaging Features Associated with a High and Low Expression of Tumor-Infiltrating Lymphocytes: A Stratified Analysis According to Molecular Subtypes.

Jiejie Zhou, Yi Jin, Haiwei Miao, Shanshan Lu, Xinmiao Liu, Yun He, Huiru Liu, Youfan Zhao, Yang Zhang, Yan-Lin Liu and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Jiejie ZhouDepartment of Radiology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Yi JinDepartment of Pathology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Haiwei MiaoDepartment of Radiology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Shanshan LuDepartment of Pathology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Xinmiao LiuDepartment of Radiology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Yun HeDepartment of Radiology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Huiru LiuDepartment of Radiology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Youfan ZhaoDepartment of Radiology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Yang ZhangDepartment of Radiological Sciences, University of California, Irvine, CA 92697, USA.
Yan-Lin LiuDepartment of Radiological Sciences, University of California, Irvine, CA 92697, USA.ORCID 0000-0003-4912-1746
Zhifang PanZhejiang Engineering Research Center of Intelligent Medicine, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Jeon-Hor ChenDepartment of Radiological Sciences, University of California, Irvine, CA 92697, USA.
Meihao WangDepartment of Radiology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Min-Ying SuDepartment of Radiological Sciences, University of California, Irvine, CA 92697, USA.ORCID 0000-0002-3069-0271
Wenzhou Medical University · CNUniversity of California, Irvine · USKaohsiung Medical University · TW

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
NCATS NIH HHS UL1 TR001414NCI NIH HHS P30 CA062203
6 · The paper itself

Abstract

A total of 457 patients, including 241 HR+/HER2- patients, 134 HER2+ patients, and 82 TN patients, were studied. The percentage of TILs in the stroma adjacent to the tumor cells was assessed using a 10% cutoff. The low TIL percentages were 82% in the HR+ patients, 63% in the HER2+ patients, and 56% in the TN patients (

Indexed as

breast cancermagnetic resonance imagingmolecular subtypetumor-infiltrating lymphocytes

Identifiers

PMID38067374
PMCPMC10705181
OpenAlexW4389206238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.